47°FFog/MistFull Forecast

FDA warns Chicago-area health system over study

CHICAGO – A warning letter from the U.S. Food and Drug Administration accuses a Chicago-area health care system of failing to get the consent of emergency room patients before enrolling them in a clinical study.

The agency criticized Advocate Health Care over a study involving patients who needed intubation, an emergency procedure in which a tube is inserted down the throat to open an airway or give medication. The study was designed to test the effectiveness of a sedative called etomidate.

The Chicago Tribune reported Saturday that the subjects were patients at Advocate Christ Medical Center in Oak Lawn.

Advocate said in a statement it has "taken immediate steps to ensure this does not occur again" and is confident the matter will soon be resolved with the FDA.


Information from: Chicago Tribune,


Get breaking and town-specific news sent to your phone. Sign up for text alerts from the Northwest Herald.

Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Reader Poll

Do you know anyone who has been affected by opioid abuse?